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Abstract
Background: Type 2 diabetes is an important preventable disease and a growing public health problem. Based on
information provided by clinical trials, we know that Type 2 diabetes can be prevented or delayed by lifestyle
intervention. In view of translating the findings of diabetes prevention research into real-life it is necessary to carry
out community-based evaluations so as to learn about the feasibility and effectiveness of locally designed and
implemented programmes. The aim of this project was to assess the effectiveness of an active real-life primary care
strategy in high-risk individuals for developing diabetes, and then evaluate its efficiency.
Methods/Design: Cost-Effectiveness analysis of the DE-PLAN (Diabetes in Europe - Prevention using Lifestyle,
physical Activity and Nutritional intervention) project when applied to a Mediterranean population in Catalonia
(DE-PLAN-CAT). Multicenter, longitudinal cohort assessment (4 years) conducted in 18 primary health-care centres
(Catalan Health Institute). Individuals without diabetes aged 45-75 years were screened using the Finnish Diabetes
Risk Score - FINDRISC - questionnaire and a 2-h oral glucose tolerance test. All high risk tested individuals were
invited to participate in either a usual care intervention (information on diet and cardiovascular health without
individualized programme), or the intensive DE-PLAN educational program (individualized or group) periodically
reinforced. Oral glucose tolerance test was repeated yearly to determine diabetes incidence. Besides measuring the
accumulated incidence of diabetes, information was collected on economic impact of the interventions in both
cohorts (using direct and indirect cost questionnaires) and information on utility measures (Quality Adjusted Life
Years). A cost-utility and a cost-effectiveness analysis will be performed and data will be modelled to predict long-
term cost-effectiveness.
Discussion: The project was intended to evidence that a substantial reduction in Type 2 diabetes incidence can
be obtained at a reasonable cost-effectiveness ratio in real-life primary health care setting by an intensive lifestyle
intervention. As far as we know, the DE-PLAN-CAT/PREDICE project represents the first assessment of long-term
effectiveness and cost-effectiveness of a public healthcare strategy to prevent diabetes within a European primary
care setting.
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1. Background
The growing impact of Type 2 Diabetes (T2D) in high
income countries requires the introduction of better and
more secure treatments, but also pushes towards the
development of new preventing strategies to reduce the
incidence and prevalence of the disease [1,2]. Many stu-
dies have been published on the efficacy of new treat-
ments of diabetes or its complications but there is still
scarce information on its prevention. As a general rule,
prevention strategies are more efficient than treating,
though there is a great reluctance from a policy perspec-
tive to transfer funds from one strategy to the other [3].
Diabetes prevention has not been prioritized and is still
not high in the health policy agenda, despite evidence
showing its ability to prevent new cases and even to pre-
vent the metabolic syndrome [4-6]; the consequences of
not including these polices are costly on the health side,
but also on other aspects of society, given the long term
inability consequences of diabetes, not to say of its sky-
rocketing incidence.
A metanalysis published in 2007 underlined the effec-
tiveness of several pharmacologic and non-pharmacolo-
gic (lifestyle) interventions to prevent or at least delay the
incidence of T2D in patients with impaired glucose toler-
ance [7]. More recently, a systematic review showed that
life-style changing interventions could be the most cost-
effective [3], though; most of the evidence came from
modelling techniques (used disease progression model to
represent the long term health benefits and costs) and
not from effectiveness evaluation programs. The eco-
nomic evaluation of the Finnish Diabetes Prevention Pro-
gram, where the event rates (both cardiovascular and
cerebrovascular) were taken from the UKPDS study,
showed that the intervention was cost-saving from the
healthcare system payers’ viewpoint and cost effective
from societal perspective [8]. Even if based on modelling,
important data were presented there on the costs of the
interventions, which are of interest for our study.
In The Netherlands, a country devoting a large share
of Gross Domestic Product to preventive programs,
costs of two lifestyle modifying programs (intensive ver-
sus community counselling on obese individuals) were
evaluated: 7 to 30 individuals were needed to prevent a
new case of diabetes in the intensive cohort, but from
30 to 1500 were needed to reach the same effectiveness
ratio at the community level. Though the costs were
grater in the intensive group (5.000 to 21.000€) when
compared to the community (2.000 to 9.000€), the cost
effectiveness ratio was much more favourable in the
intensive group (3.100 to 3.900€/QALY versus 3.900 to
5.500€/QALY) [9].
It is accepted that a well designed and implemented
program on T2D prevention is more effective (and
even cost-effective) than doing nothing [10,11]. How-
ever, as suggested by the US Diabetes Prevention Pro-
gram (DPP) the cost depends greatly on the program
implementation costs and the contextual characteris-
tics (health care system characteristics) [12,13]. In fact,
two different reviews of the same program did not
reach the same conclusions on the cost-effectiveness of
using metformin, and despite it could be argued that
the DPP had a too expensive life-style intervention
strategy, it is evident that the efficacy and efficiency in
this programs may vary depending on the wealth of
the participants but also on their dietary habits and
the ability of an intervention to significantly reduce
weight [14].
In all, most of the economic evaluations consider
medicines and modelling techniques instead of collect-
ing real data on effectiveness and resources used during
the intervention. In addition primary prevention is only
marginally assessed. Despite it may be difficult to prove,
it seems plausible to prove that prevention is efficacious,
effective and efficient. The obvious limiting factor is the
capacity to prove short and long term benefits, and the
ability to reduce uncertainty on the effect of a long-last-
ing intervention [15]. In such context, it is crucial to
define both the target population and the resources
availability (time, capital and labour).
2. Design and methods
Hypothesis
Preventive interventions are both effective and efficient
in high risk individuals to develop T2D.
Objectives
1. The primary objective is to prove the cost-effective-
ness of the DE-PLAN-CAT life-stile intervention, where
a usual-care informative strategy was compared with an
intensive intervention to prevent T2D in high risk
individuals.
2. Secondary objectives were to assess the quality of
life of such individuals with the validated 15D question-
naire before, during and after the intervention.
3. Third, to analyse the cost-effectiveness of such
intervention on a generalized level, by using simulation
models.
Study Design
Using data from the DE-PLAN-CAT study, different
sub-analysis will be performed:
1. Direct and indirect cost analysis of both strategies
2. Cost-effectiveness analysis of both strategies
3. Cost utility analysis of both interventions
4. Long term modelling simulation on the cost-effec-
tiveness of both interventions.
Costa et al. BMC Public Health 2011, 11:623
http://www.biomedcentral.com/1471-2458/11/623
Page 2 of 7
Setting
The original DE-PLAN-CAT study was performed in 18
Spanish primary health-care centres in Catalonia (Cata-
lan Health Institute) (figure 1).
Sample size calculation
The participating centres were selected in a stratified
manner covering primary care services of 315,703 inha-
bitants (4.5% of the population in Catalonia). The neces-
sary sample of participating subjects was obtained
mainly from the computerized list of the public primary
health care system. In addition, several participating
teams noticed the initiative and also contacted with
local authorities or pharmacies in view of implement the
study. The sample size was calculated regarding avail-
able data on diabetes incidence in high-risk Catalan
population [16]. Therefore, it was assumed that the
mean annual incidence in the usual care intervention
group would be 7.5% and the mean expected incidence
in the group of maximum impact (intensive intervention
group) would be 3.25% (50% reduction in the yearly
rate). Basic estimates for calculating the sample size also
included the following hypothesis: 35% positive high-risk
screenees by the FINDRISC, 10% negative screenees
with prediabetes diagnostic criteria at blood test, 20% of
individuals having undiagnosed diabetes and a theoreti-
cal distribution between cases in the usual care, inten-
sive individualized and intensive group interventions
close to 1:1:1. Thus, allowing for a discontinuation rate
of 30% it was expected to screen a minimum of 1650
subjects and include a minimum of 550 in the interven-
tion with a type 1 error of 5%, with 80% power (beta =
20%) at the two-tailed 5% significance level.
Subjects and Clinical Intervention
According to the original study, an active public health
programme was applied to a Mediterranean population
based in Catalonia (Spain). Caucasian individuals (n =
2054) without known diabetes aged 45-75 years were
evaluated by general practitioners in 18 primary health-
care centres. The FINDRISC questionnaire was used for
screening as it has been well validated across Europe to
elicit the risk of developing T2D. This 8-item question-
naire (0-26 points in the used version), collects
Figure 1 General plan of DE-PLAN-CAT project.
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information on age, sex, weight and height, waist cir-
cumference, use of concomitant medication (blood pres-
sure), history of blood glucose disorders, physical
activity and daily consumption of vegetables, fruits or
berries.
All subjects showing to have a high risk of T2D (FIN-
DRISC score > 14 and/or non-diabetic hyperglycaemia
at blood test) were included in the lifestyle intervention
study (n = 552, 4-year follow-up). All individuals with
severe psychiatric disease, chronic kidney or liver disease
or blood disorders, were excluded.
Anthropometric parameters were determined by
trained nurses. Body weight and height were measured
in light clothing and without shoes. Waist circumference
was measured midway between the lowest rib and the
iliac crest. A 2-h 75-g oral glucose tolerance test was
carried out according to the World Health Organization
(WHO) standards with measurements of fasting plasma
glucose and 2-h post-load glucose. Simultaneously lipid
profile and HbA1C determinations were performed.
These measurements were repeated at the annual fol-
low-up visits.
The intervention consisted of two steps (initial and
further reinforcement) and two elective interventions
(informative or intensive). In the usual care informative
intervention, each participant was told about the risk of
developing diabetes and its possible health conse-
quences, and a standard training material was provided;
at their next visits to the physician, standard reminders
were given. The intensive intervention consisted of a
six-hour educational program (divided in 2 to 4 ses-
sions) to be performed either individually or in small
groups (5 to 15 people). The intervention was based on
motivation, peer support and positive feed-back and the
core of the information given was about the risks of
having diabetes, the Mediterranean diet together with
nutritional advice, the beneficial effects of exercise and
tobacco cessation advice. Participants were reminded
(telephone call) about the date and hour of their next
group session to ensure compliance, and every 6-week
(minimum) they were contacted (also by telephone). In
2 out of 8 centres SMS sending was preferred for con-
tinuous intervention. Process-based evaluation of the
individual risk and response to the intervention were
provided to encourage the lifestyle modification. Figure
2 describe the study design.
Economic Analysis
Specific DE-PLAN approach for cost assessment was
designed incorporating WHO-CHOICE concept for ana-
lyzing and presenting resources used at different levels and
in two periods of programme implementation. These are:
a) Start-up and post start-up costs
The start-up period covers pre-implementation
phase of the programme including: planning, con-
sensus meetings, organizing, training of the person-
nel, printing materials, informing. These costs are
spent only once for the organization of the preven-
tion programme in each country. Programme can be
extended to another region without necessity to
cover again the total amount of start-up costs.
The post start-up period covers implementation and
running the programme. These costs are analyzed to
mirror the main steps of DE-PLAN project:
Step 1: Selection of the subjects
Step 2: Intensive intervention
Step 3: Continuous intervention
b) Cost of “management level” and “participant
level”
Cost at management level consider costs for coordi-
nating of the intervention in each participating cen-
tre including planning, organizing, monitoring and
supervision of the intervention, training of the per-
sonnel during both start-up and post start-up peri-
ods of the programme.
Figure 2 Diagram of the DE-PLAN-CAT/PREDICE cohort.
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Costs at participant level include all resources used
at the point of delivery of the intervention (provider
of the intervention) such as: costs of screening, test-
ing with the oral glucose tolerance test and other
biochemical examinations, educating, exercising etc.
Changes in use of health services due to intervention
are also considered.
Within the presented structure of costs assessment the
following 8 forms were used in order to collect data to
assess direct (medical and non-medical) and indirect
costs of the intervention.
1. E01 Form: It evaluates the resources used in the
screening which includes the identification and selection
of the participants in the intervention programme. The
programme measures the time needed to complete the
FINDRISC questionnaire, the cost in human resources to
carry out the activity and other specifications such as the
time employed for the analytical tests. It also measures
the time to complete the intensive intervention on life-
style identifying all the professionals involved; telephone
calls and material provided (leaflets, photocopies, etc.). A
randomised sample from each centre will be evaluated.
2. E02 Form: It also records the number of contacts
with the health system that each participant required to
finish the stage, the cost of materials used for blood
tests (personnel not included), the number of oral glu-
cose tolerance test carried out, telephone calls and aver-
age duration of the calls, writing material provided and
photocopies, extra-time and number of personnel and
dates of the specific training in the programme of the
personnel collaborating in the study.
3. E03 Form: The purpose is to assess the change in
(i) costs of medical care outside the DE-PLAN pro-
gramme, which the intervention might cause- by either
side effects or by improvement of health and (ii) indirect
costs to society. This form adds up the use of different
types of health services by DE-PLAN participants during
the programme. In other words information collected
with this form is on the number and duration of hospi-
talizations, ordinary visits to health centres, the number
of visits to emergency units, to specialists and other
healthcare providers, whether the person is currently
working, if they have been on sick leave and for how
long. The period of data considered is for the year
before the participant entered the study and for the per-
iod of programme implementation.
4. E04 Form: The purpose of the form supplied to the
different centres participating in the program is to iden-
tify an average (per group and per participant) personnel
time necessary to perform the intensive intervention.
This form collects data on the intensive intervention,
noting the duration and characteristics of the interven-
tion group sessions as well as the personnel who gave
these sessions, the topic and average length of the
session.
5. E05 Form: This form deals with the continuous
intervention questionnaire which collects the average
number of participants, total number of follow-up
phone calls and the time expended by professionals.
6. E06 Form: The purpose is to collect data on man-
agement of the intervention in participating centres
(including resources necessary for planning, organising,
monitoring, supervision and training of personnel per-
forming the interventyion). It collects data regarding
personnel differentiating among qualifications, responsi-
bilities, effective time spent dedicated to the project the
total length of time in which they are committed to the
project. It includes also materials and supplies at market
price; transport costs (travel expenses, parking, motor-
way tolls, etc). The costs of the telephone and other
means of messaging (e.g. SMS) will be estimated. It also
includes estimates of the cost of the carrying out of the
screen tests (exclusively).
7. E07 Form: This refers to the macroeconomic infor-
mation about the Spanish and Catalan health systems
(for European Project purposes).
8. E08 Form: This collects data necessary to identify
costs incurred by participant due to intervention includ-
ing: the cost of transport to the centre or the time spent
travelling; the time spent going to gymnasiums or swim-
ming pools as part of the programme; and costs to the
participants which do not fall within the programme
(books, gym or sports centre fees, equipment, classes
and so on). Also included are the changes in the
monthly cost of food, drink and restaurant bills before
and after the educational intervention.
Organization, Data Collection and Analysis
Organization
A multidisciplinary coordinating committee was estab-
lished (DE-PLAN-Catalonia Coordinating Committee)
to implement and coordinate the study, At the Catalan
Institute of Health, every providing centre is composed
of many independent ‘teams’ (physician, nurses and
other staff that manage their own activity though coor-
dinated at a centre level); at each participating centre
one team was invited to join the committee together
with the managing and specialized professionals). Data
were collected and monitored electronically. All centres
were computerized regarding data collection and moni-
toring. The Research Unit of Reus-Tarragona provides,
besides coordination and steering, methodological sup-
port and treatment of the data.
Data Collection
Data were initially collected on paper forms by the col-
laborating investigators, and an independent non-
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epidemiologist introduced the data into the database. To
ensure quality and avoid discrepancies, files were
reviewed by an expert epidemiologist. In case of data
inconsistencies, the teams were required to solve the
problem by a “query - response” electronic form. An
additional check was performed after entering the data
in the database, to avoid inconsistencies due to any mis-
takes in the data input.
Analysis
Cost-effectiveness (and cost-utility) ratios will be ana-
lyzed for both interventions (informative vs. intensive),
and an incremental cost-effectiveness (cost-utility) ratio
will also be calculated. Direct and indirect costs will be
accounted for as described in the above mentioned
forms and measured according to reliable available rates
in the Catalan health service, thus providing internal
and external consistency.
The main outcome measures will then be (for both arms
and the difference): average costs, average effectiveness,
average cost-effectiveness and cost-utility ratios, and incre-
mental cost-effectiveness and cost-utility ratios. The com-
parator for intensive and informative study group is
control group (no intervention). Utility measures will be
extracted from the 15D questionnaire, and from there we
will elicit QALYs gained for both interventions [17,18].
For the long term simulation model, we will use input
from the trial and run the model to predict long term
costs, effects and incremental cost-effectiveness ratios,
using both MS Excel files and TreeAge Data [19].
3. Discussion and points of interest
This study will present a new analysis of the effective-
ness of T2D prevention. If data confirm our hypothesis,
this will help policymakers’ to allocate larger invest-
ments in prevention rather than treatment. It is impor-
tant to note that data feeding the analysis will be
collected from a real life environment, and despite the
trial will be set up on a research basis and under a
quasi-controlled environment, we believe we can assume
these will be effectiveness data. In fact the efficiency
analysis will be done including all interventions aimed
to be sustained in the large-scale implementation phase.
Of note also, the study includes non-service cost data:
not only has this eagerly been attempted before, but
also it will provide important and relevant information
for policy-making.
Finally, we would like to stress that we aim to publish
the results of this and accompanying studies to inform
policy making and to induce a needed change.
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